202 related articles for article (PubMed ID: 11688841)
1. Clinical features and therapeutic outcomes of 65 patients with acromegaly at Tokyo Women's Medical University.
Fukuda I; Hizuka N; Murakami Y; Itoh E; Yasumoto K; Sata A; Takano K
Intern Med; 2001 Oct; 40(10):987-92. PubMed ID: 11688841
[TBL] [Abstract][Full Text] [Related]
2. The influence of age on the GH-IGF1 axis in patients with acromegaly.
Tanimoto K; Hizuka N; Fukuda I; Takano K; Hanafusa T
Eur J Endocrinol; 2008 Oct; 159(4):375-9. PubMed ID: 18653547
[TBL] [Abstract][Full Text] [Related]
3. Acromegaly.
Scacchi M; Cavagnini F
Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
[TBL] [Abstract][Full Text] [Related]
4. A follow-up of 130 patients with acromegaly in a single centre.
Bolanowski M; Zatonska K; Kaluzny M; Zielinski G; Bednarek-Tupikowska G; Bohdanowicz-Pawlak A; Daroszewski J; Szymczak J; Podgorski JK
Neuro Endocrinol Lett; 2006 Dec; 27(6):828-32. PubMed ID: 17187024
[TBL] [Abstract][Full Text] [Related]
5. Clinical-biochemical correlations in acromegaly at diagnosis and the real prevalence of biochemically discordant disease.
Mercado M; Espinosa de los Monteros AL; Sosa E; Cheng S; Mendoza V; Hernández I; Sandoval C; Guinto G; Molina M
Horm Res; 2004; 62(6):293-9. PubMed ID: 15542931
[TBL] [Abstract][Full Text] [Related]
6. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
Costa AC; Rossi A; Martinelli CE; Machado HR; Moreira AC
J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
[TBL] [Abstract][Full Text] [Related]
7. The Liege Acromegaly Survey (LAS): a new software tool for the study of acromegaly.
Petrossians P; Tichomirowa MA; Stevenaert A; Martin D; Daly AF; Beckers A
Ann Endocrinol (Paris); 2012 Jun; 73(3):190-201. PubMed ID: 22682917
[TBL] [Abstract][Full Text] [Related]
8. Has acromegaly been diagnosed earlier?
Ohno H; Yoneoka Y; Jinguji S; Watanabe N; Okada M; Fujii Y
J Clin Neurosci; 2018 Feb; 48():138-142. PubMed ID: 29113856
[TBL] [Abstract][Full Text] [Related]
9. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
[TBL] [Abstract][Full Text] [Related]
10. Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly.
Serri O; Beauregard C; Hardy J
J Clin Endocrinol Metab; 2004 Feb; 89(2):658-61. PubMed ID: 14764777
[TBL] [Abstract][Full Text] [Related]
11. Acromegaly: presentation, morbidity and treatment outcomes at a single centre.
Anagnostis P; Efstathiadou ZA; Polyzos SA; Adamidou F; Slavakis A; Sapranidis M; Litsas ID; Katergari S; Selalmatzidou D; Kita M
Int J Clin Pract; 2011 Aug; 65(8):896-902. PubMed ID: 21679284
[TBL] [Abstract][Full Text] [Related]
12. Clinical experiences and success rates of acromegaly treatment: the single center results of 62 patients.
Evran M; Sert M; Tetiker T
BMC Endocr Disord; 2014 Dec; 14():97. PubMed ID: 25511633
[TBL] [Abstract][Full Text] [Related]
13. The acromegaly registry of ten different centers in Turkey.
Keskin Ç; Demir Ö; Karcı AÇ; Berker D; Cantürk Z; Yaylali GF; Topsakal Ş; Ersoy R; Bayram F; Ertörer ME; Bozkırlı E; Haydardedeoğlu F; Dilekçi ENA; Ay SA; Cansu GB; Şahin M; Emral R; Çorapçıoğlu D
Growth Horm IGF Res; 2020; 53-54():101322. PubMed ID: 32417639
[TBL] [Abstract][Full Text] [Related]
14. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
Gondim JA; Almeida JP; de Albuquerque LA; Gomes E; Schops M; Ferraz T
Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
[TBL] [Abstract][Full Text] [Related]
15. Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center.
Barrande G; Pittino-Lungo M; Coste J; Ponvert D; Bertagna X; Luton JP; Bertherat J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3779-85. PubMed ID: 11061538
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and treatment outcomes of micromegaly - acromegaly with apparently normal basal GH: A retrospective study and literature review.
Inacio I; Fonseca L; Amado A; Benido V; Ribeiro I; Dores J; Amaral C; Cardoso MH
Endocr Regul; 2022 Apr; 56(2):87-94. PubMed ID: 35489048
[No Abstract] [Full Text] [Related]
17. Monitoring disease activity using GH and IGF-I in the follow-up of 501 patients with acromegaly.
Sherlock M; Aragon Alonso A; Reulen RC; Ayuk J; Clayton RN; Holder G; Sheppard MC; Bates A; Stewart PM
Clin Endocrinol (Oxf); 2009 Jul; 71(1):74-81. PubMed ID: 19178529
[TBL] [Abstract][Full Text] [Related]
18. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic strategies in somatotroph adenomas with extrasellar extension: role of the medical approach, a consensus study of the French Acromegaly Registry].
Jaquet P; Cortet-Rudelli Ch; Sassolas G; Morange-Ramos I; Chanson P; Brue T; Andrieu JM; Beckers A; Bertherat J; Borson-Chazot F; Brassier G; Caron P; Cogne M; Cottier JP; Delemer B; Dufour H; Enjalbert A; Figarella-Branger D; Gaillard R; Gueydan M; Jan M; Kuhn JM; Raingeard I; Regis J; Roger P; Rohmer V; Sadoul JL; Saveanu A; Tabarin A; Travers N; Trouillas J;
Ann Endocrinol (Paris); 2003 Dec; 64(6):434-41. PubMed ID: 15067248
[TBL] [Abstract][Full Text] [Related]
20. Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly.
Freda PU; Wardlaw SL; Post KD
J Neurosurg; 1998 Sep; 89(3):353-8. PubMed ID: 9724106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
